CL2014001265A1 - Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer. - Google Patents

Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer.

Info

Publication number
CL2014001265A1
CL2014001265A1 CL2014001265A CL2014001265A CL2014001265A1 CL 2014001265 A1 CL2014001265 A1 CL 2014001265A1 CL 2014001265 A CL2014001265 A CL 2014001265A CL 2014001265 A CL2014001265 A CL 2014001265A CL 2014001265 A1 CL2014001265 A1 CL 2014001265A1
Authority
CL
Chile
Prior art keywords
axl
uracil
cancer
useful
treatment
Prior art date
Application number
CL2014001265A
Other languages
Spanish (es)
Inventor
Dandu Reddeppareddy
L Hudkins Robert
A Josef Kurt
P Prout Catherine
Tripathy Rabindranath
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of CL2014001265A1 publication Critical patent/CL2014001265A1/en

Links

CL2014001265A 2011-11-14 2014-05-14 Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer. CL2014001265A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161559312P 2011-11-14 2011-11-14
US201213065019A 2012-11-14 2012-11-14

Publications (1)

Publication Number Publication Date
CL2014001265A1 true CL2014001265A1 (en) 2014-08-22

Family

ID=52002374

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001265A CL2014001265A1 (en) 2011-11-14 2014-05-14 Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer.

Country Status (1)

Country Link
CL (1) CL2014001265A1 (en)

Similar Documents

Publication Publication Date Title
SG11202012656WA (en) Heterocyclic compounds useful in the treatment of disease
SG10202111808WA (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
HK1216025A1 (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer -24-
CL2014002873A1 (en) Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer.
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
EP3019491A4 (en) Kinase inhibitors for the treatment of disease
IL238571A0 (en) Bruton's tyrosine kinase inhibitors
CL2015000711A1 (en) Compounds derived from bis (fluoroalkyl) -1,4-benzodiazepinone as notch inhibitors; Pharmaceutical composition and use in cancer treatment.
EA201400178A1 (en) BREAST CANCER TREATMENT
CL2014001858A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides, mdm2 antagonists; pharmaceutical composition; and its use in the treatment or prophylaxis of cancer.
CL2014002726A1 (en) Compounds derived from pyrrolopyrimidine and purine; pharmaceutical composition; useful in the treatment of cancer (div. sol. 566-14).
BR112014009755A2 (en) cancer treatment with tor kinase inhibitors
CL2015000873A1 (en) Methods for the treatment of alport syndrome.
EA201171367A1 (en) VINYLINDASOLYL COMPOUNDS
EA201590962A1 (en) NEW CONNECTIONS
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
SG11201502522WA (en) 1,2,4-triazine derivatives for the treatment of viral infections.
EP2844256A4 (en) Treating neural disease with tyrosine kinase inhibitors
CL2015000926A1 (en) Process for the elaboration of compounds for the treatment of cancer derived from azetidin-1-yl-methanone and intermediary compounds.
ZA201706402B (en) C.novyi for the treatment of solid tumors in humans
CL2015001202A1 (en) Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer.
BR112015005361A2 (en) bruton tyrosine kinase inhibitors
DK2931296T3 (en) DISEASE TREATMENT INCLUDING MUCIN
EP3733184C0 (en) Pyrimidine compounds for use in the treatment of cancer
CL2014001323A1 (en) Compounds derived from 3-phenyl-isoquinolin-1 (2h) -one, parp-1 inhibitors; preparation procedure; pharmaceutical composition; and use in the treatment of cancer.